Skip to search formSkip to main contentSkip to account menu

Sandimmune

Known as: Sandimmun 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
OBJECTIVES To examine the clinical effectiveness and cost-effectiveness of the newer immunosuppressive drugs for renal… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND The novel agent sirolimus (SRL; Rapamune; rapamycin) inhibits the immune response by a mechanism distinct from those… 
Highly Cited
1998
Highly Cited
1998
This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun® and Neoral®, in patients… 
Highly Cited
1995
Highly Cited
1995
1. Less than 5% of a dose of the conventional oral formulation of cyclosporin, Sandimmun, is absorbed in liver transplant… 
Review
1992
Review
1992
Summary Human studies using oral cyclosporin A (CyA; Sandimmun®) therapy for psoriasis have been in progress for nearly 9 years… 
Highly Cited
1989
Highly Cited
1989
Cyclosporin A (ciclosporin), a potent and clinically important immunosuppressive drug (Sandimmun), represents the main component…